Home LiteratureArticle Details
PMID: 8897008 Published · ppublish English Comparative Study Journal Article Research Support, U.S. Gov't, P.H.S.

Decreased insulin action and insulin secretion predict the development of impaired glucose tolerance.

Diabetologia ·Vol. 39 ·No. 10 ·1996-10-00 ·Pages 1201-7

Haffner SM, Miettinen H, Gaskill SP, Stern MP

Abstract

The relative importance of insulin resistance and abnormal insulin secretion as risk factors for the development of impaired glucose tolerance (IGT) is controversial. Few prospective data are available on metabolic precursors of IGT. We examined the relation of fasting serum insulin level (as a marker of insulin resistance) and change in insulin/glucose ratio (delta I30/ delta G30) over the first 30 min after glucose ingestion (as a marker of insulin secretion) as predictors of the 7-year development of IGT in 839 Mexican Americans and non-Hispanic whites with normal glucose tolerance at baseline from the San Antonio Heart Study. IGT eventually developed in 148 subjects. When modelled separately, fasting serum insulin (odds ratio (OR) = 2.60, 95% confidence interval (CI) = 1.58, 4.28, p < 0.005), but not delta I30/ delta G30 (OR = 0.80, 95% CI = 0.50, 1.27, p = 0.339) predicted the development of IGT. However, when both variables were included in the same logistic regression model, fasting serum insulin (OR = 3.50, 95% CI = 1.97, 6.21, p < 0.001) and low delta I30/ delta G30 (OR = 0.48, 95% CI = 0.28, 0.82, p = 0.008) both predicted IGT. These results were basically unchanged after further adjustment for obesity, body fat distribution and fasting plasma glucose level. We conclude that both decreased insulin secretion (as assessed by low delta I30/ delta G30) and increased insulin resistance (as assessed by fasting serum insulin) predict the development of IGT and are thus early precursors of non-insulin-dependent diabetes mellitus; further studies of insulin secretion should take into account the level of basal insulin resistance.

MeSH Terms
Adult Analysis of Variance Blood Glucose/drug effects,metabolism Body Mass Index Ethnicity Fasting Female Glucose Intolerance/epidemiology Glucose Tolerance Test Humans Insulin/blood,metabolism,pharmacology Insulin Resistance Insulin Secretion Male Middle Aged Prospective Studies Risk Factors Sex Characteristics
Chemicals
Blood Glucose Insulin
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Haffner S M
Department of Medicine, University of Texas Health Science Center at San Antonio 78284-7873, USA.
Miettinen H
Gaskill S P
Stern M P
References (41)
41 references, click to expand
  1. Which comes first in non-insulin-dependent diabetes mellitus: insulin resistance or beta-cell failure? Both come first.
    JAMA. 1995 Jun 21;273(23):1878-9 PMID: 7776508
  2. Aspects of the pathogenesis of type 2 diabetes.
    Endocr Rev. 1984 Summer;5(3):395-410 PMID: 6381035
  3. A two-step model for development of non-insulin-dependent diabetes.
    Am J Med. 1991 Feb;90(2):229-35 PMID: 1996593
  4. Hyperinsulinemia in a population at high risk for non-insulin-dependent diabetes mellitus.
    N Engl J Med. 1986 Jul 24;315(4):220-4 PMID: 3523246
  5. Association of elevated fasting C-peptide level and increased intra-abdominal fat distribution with development of NIDDM in Japanese-American men.
    Diabetes. 1990 Jan;39(1):104-11 PMID: 2210052
  6. Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians.
    N Engl J Med. 1993 Dec 30;329(27):1988-92 PMID: 8247074
  7. Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function.
    Diabetes. 1993 Nov;42(11):1663-72 PMID: 8405710
  8. Impaired glucose tolerance as a disorder of insulin action. Longitudinal and cross-sectional studies in Pima Indians.
    N Engl J Med. 1988 May 12;318(19):1217-25 PMID: 3283552
  9. Risk factors for developing non-insulin dependent diabetes: a 10 year follow up of men in Uppsala.
    BMJ. 1991 Sep 28;303(6805):755-60 PMID: 1932936
  10. Disproportionately elevated proinsulin in Pima Indians with noninsulin-dependent diabetes mellitus.
    J Clin Endocrinol Metab. 1990 May;70(5):1247-53 PMID: 2186054
  11. How good a marker is insulin level for insulin resistance?
    Am J Epidemiol. 1993 May 1;137(9):959-65 PMID: 8317453
  12. Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus.
    N Engl J Med. 1989 Aug 10;321(6):337-43 PMID: 2664520
  13. Risk factors for NIDDM in white population. Paris prospective study.
    Diabetes. 1991 Jul;40(7):796-9 PMID: 2060716
  14. Decreased insulin secretion and increased insulin resistance are independently related to the 7-year risk of NIDDM in Mexican-Americans.
    Diabetes. 1995 Dec;44(12):1386-91 PMID: 7589843
  15. Plasma insulin, C-peptide, and proinsulin concentrations in obese and nonobese individuals with varying degrees of glucose tolerance.
    J Clin Endocrinol Metab. 1993 Jan;76(1):44-8 PMID: 8421101
  16. Banting lecture 1990. Beta-cells in type II diabetes mellitus.
    Diabetes. 1991 Feb;40(2):166-80 PMID: 1991568
  17. Relationship between the plasma insulin response to oral glucose and insulin-stimulated glucose utilization in normal subjects.
    Diabetes. 1984 May;33(5):460-3 PMID: 6373455
  18. Understanding oral glucose tolerance: comparison of glucose or insulin measurements during the oral glucose tolerance test with specific measurements of insulin resistance and insulin secretion.
    Diabet Med. 1994 Apr;11(3):286-92 PMID: 8033528
  19. Fasting serum insulin concentration and early insulin response as risk determinants for developing diabetes.
    Diabet Med. 1990 Jun;7(5):407-13 PMID: 2142037
  20. The natural history of impaired glucose tolerance in the Pima Indians.
    N Engl J Med. 1988 Dec 8;319(23):1500-6 PMID: 3054559
  21. Pancreatic beta-cell dysfunction as the primary genetic lesion in NIDDM. Evidence from studies in normal glucose-tolerant individuals with a first-degree NIDDM relative.
    JAMA. 1995 Jun 21;273(23):1855-61 PMID: 7776502
  22. Diabetes incidence and prevalence in Pima Indians: a 19-fold greater incidence than in Rochester, Minnesota.
    Am J Epidemiol. 1978 Dec;108(6):497-505 PMID: 736028
  23. Cardiovascular disease risk factors as predictors of type 2 (non-insulin-dependent) diabetes mellitus in elderly subjects.
    Diabetologia. 1993 Jun;36(6):553-9 PMID: 8335178
  24. Role of reduced suppression of glucose production and diminished early insulin release in impaired glucose tolerance.
    N Engl J Med. 1992 Jan 2;326(1):22-9 PMID: 1727062
  25. A comparison of three indicators for identifying Mexican Americans in epidemiologic research. Methodological findings from the San Antonio Heart Study.
    Am J Epidemiol. 1986 Jan;123(1):96-112 PMID: 3940446
  26. Increased incidence of type II diabetes mellitus in Mexican Americans.
    Diabetes Care. 1991 Feb;14(2):102-8 PMID: 2060411
  27. Beta-cell dysfunction, rather than insulin insensitivity, is the primary defect in familial type 2 diabetes.
    Lancet. 1986 Aug 16;2(8503):360-4 PMID: 2874367
  28. The metabolic profile of NIDDM is fully established in glucose-tolerant offspring of two Mexican-American NIDDM parents.
    Diabetes. 1992 Dec;41(12):1575-86 PMID: 1446799
  29. Methods and prevalence of non-insulin-dependent diabetes mellitus in a biethnic Colorado population. The San Luis Valley Diabetes Study.
    Am J Epidemiol. 1989 Feb;129(2):295-311 PMID: 2912042
  30. Upper body and centralized adiposity in Mexican Americans and non-Hispanic whites: relationship to body mass index and other behavioral and demographic variables.
    Int J Obes. 1986;10(6):493-502 PMID: 3804566
  31. Insulin responses in equivocal and definite diabetes, with special reference to subjects who had mild glucose intolerance but later developed definite diabetes.
    Diabetes. 1977 Oct;26(10):944-52 PMID: 908463
  32. Proinsulin and specific insulin concentration in high- and low-risk populations for NIDDM.
    Diabetes. 1994 Dec;43(12):1490-3 PMID: 7958504
  33. Serum proinsulin levels at fasting and after oral glucose load in patients with type 2 (non-insulin-dependent) diabetes mellitus.
    Diabetologia. 1988 Jun;31(6):355-60 PMID: 3046976
  34. Sex difference in the effects of sociocultural status on diabetes and cardiovascular risk factors in Mexican Americans. The San Antonio Heart Study.
    Am J Epidemiol. 1984 Dec;120(6):834-51 PMID: 6507426
  35. Plasma insulin response among Nauruans. Prediction of deterioration in glucose tolerance over 6 yr.
    Diabetes. 1987 Feb;36(2):179-86 PMID: 3542644
  36. Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents.
    Ann Intern Med. 1990 Dec 15;113(12):909-15 PMID: 2240915
  37. Incidence of type II diabetes in Mexican Americans predicted by fasting insulin and glucose levels, obesity, and body-fat distribution.
    Diabetes. 1990 Mar;39(3):283-8 PMID: 2407581
  38. Risk factors for worsening to diabetes in subjects with impaired glucose tolerance.
    Diabetologia. 1984 Jan;26(1):44-9 PMID: 6368299
  39. A comparison between the minimal model and the glucose clamp in the assessment of insulin sensitivity across the spectrum of glucose tolerance. Insulin Resistance Atherosclerosis Study.
    Diabetes. 1994 Sep;43(9):1114-21 PMID: 8070611
  40. Insulin secretion, insulin action, and hepatic glucose production in identical twins discordant for non-insulin-dependent diabetes mellitus.
    J Clin Invest. 1995 Feb;95(2):690-8 PMID: 7860750
  41. Insulin deficiency in non-insulin-dependent diabetes.
    Lancet. 1989 Feb 11;1(8633):293-5 PMID: 2563455
Article Info
Journal
Diabetologia
Abbr.
Diabetologia
ISSN
0012-186X
DOI
10.1007/BF02658507
Published
1996-10-00
Pages
1201-7
Language
English
Region
Germany
NLM ID
0006777
Subset
IM
Grants
NHLBI NIH HHS · R01 HL 24799 · United States
NHLBI NIH HHS · R37 HL 36820 · United States
External Links
PubMed source DOI: 10.1007/BF02658507 View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2